Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL10686252

N.O=C(O)c1ccccc1OS(=O)(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.52
ALDH1A1 P00352 8/20 0.52
HSD17B10 Q99714 6/20 0.52
HPGD P15428 6/20 0.52
HMGB1 P09429 2/20 0.52
NAPRT Q6XQN6 2/20 0.52
ESR1 P03372 1/20 0.52
ITGB3 P05106 1/20 0.52
ITGA2B P08514 1/20 0.52
TSHR P16473 1/20 0.52
GGT1 P19440 1/20 0.52
PTGS1 P23219 1/20 0.52
PTGS2 P35354 1/20 0.52
BLM P54132 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
MAPT P10636 2/20 0.50
USP2 O75604 1/20 0.50
PDE3A Q14432 1/20 0.50
HTT P42858 2/20 0.49
KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27361627 1.00 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
Fluoride SCHEMBL28813253 0.98 KDM4E (0.50) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL26647 0.98 KDM4E (0.53) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL6812015 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL8769958 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL3169153 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL6567084 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL7065758 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
SCHEMBL291628 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1
Water SCHEMBL3696220 0.96 KDM4E (0.52) KDM4EALDH1A1HSD17B10HPGDHMGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116064025-A Clean fracturing fluid thickener for low-permeability oil and gas field and preparation method thereof 西安石油大学 2023-05-05 CN claimed
CN-116023926-A Instant clean fracturing fluid thickener and preparation method thereof 西安石油大学 2023-04-28 CN claimed
EP-0277273-A1 Diazotype compositions Andrews Paper and Chemical Co., Inc. (US) 1988-08-10 EP claimed
US-4137972-A Acidizing reservoirs while chelating iron with sulfosalicylic acid SHELL OIL COMPANY (US) 1979-02-06 US claimed
CN-116605893-B Method for synthesizing ultrapure battery grade lithium carbonate by retired lithium battery 赣州吉锐新能源科技股份有限公司 2024-10-29 CN disclosed
CN-116605893-A Method for synthesizing ultrapure battery grade lithium carbonate by retired lithium battery 赣州吉锐新能源科技股份有限公司 2023-08-18 CN disclosed
CN-116064025-A Clean fracturing fluid thickener for low-permeability oil and gas field and preparation method thereof 西安石油大学 2023-05-05 CN disclosed
US-11147881-B2 Controlled drug release liposome compositions and methods thereof TAIWAN LIPOSOME COMPANY, LTD. (TW) 2021-10-19 US disclosed
CN-107681143-B Nickel-cobalt lithium aluminate cathode material and preparation method thereof 赣南师范大学 2020-04-21 CN disclosed
US-20190216932-A1 CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF TAIWAN LIPOSOME COMPANY, LTD. (TW) 2019-07-18 US disclosed
US-10220095-B2 Controlled drug release liposome compositions and methods thereof TAIWAN LIPOSOME COMPANY, LTD (TW) 2019-03-05 US disclosed
US-20170266295-A1 CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF TAIWAN LIPOSOME COMPANY, LTD. (TW) 2017-09-21 US disclosed
CN-103696018-A Novel fluorescent crystal material ammonium sulfosalicylate, and preparation and application thereof FUJIAN MATTER STRUCTURE 2014-04-02 CN disclosed
US-4167214-A Process for stably sequestering iron while acidizing a reservoir SHELL OIL COMPANY (US) 1979-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10220095-B2 Controlled drug release liposome compositions and methods thereof LIPA, CEL, NPC1L1 KDM4E 2040/4885ALDH1A1 3968/4885HSD17B10 2246/4885
US-11147881-B2 Controlled drug release liposome compositions and methods thereof LIPA, CEL, NPC1L1 KDM4E 2040/4885ALDH1A1 3968/4885HSD17B10 2246/4885
US-20190216932-A1 CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF LIPA, CEL, NPC1L1 KDM4E 2040/4885ALDH1A1 3968/4885HSD17B10 2246/4885
US-20170266295-A1 CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF LIPA, CEL, NPC1L1 KDM4E 2040/4885ALDH1A1 3968/4885HSD17B10 2246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.